title: UDP-glucuronosyltransferase-dependent bioactivation of clofibric acid to a DNA-damaging intermediate in mouse hepatocytes.
abstract: Glucuronidation of a number of carboxyl-containing drugs generates reactive acyl glucuronide metabolites. These electrophilic species alkylate cell proteins and may be implicated in the pathogenesis of a number of toxic syndromes seen in patients receiving the parent aglycones. Whether acyl glucuronides also attack nuclear DNA is unknown, although the acyl glucuronide formed from clofibric acid was recently found to decrease the transfection efficiency of phage DNA and generate strand breaks in plasmid DNA in vitro. To determine if such a DNA damage occurs within a cellular environment, the comet assay (i.e. single-cell gel electrophoresis) was used to detect DNA lesions in the nuclear genome of isolated mouse hepatocytes cultured with clofibric acid. Overnight exposure to 50 microM and higher concentrations of clofibric acid produced concentration-dependent increases in the comet areas of hepatocyte nuclei, with 1 mM clofibrate producing a 3.6-fold elevation over controls. These effects closely coincided with culture medium concentrations of the glucuronide metabolite formed from clofibric acid, 1-O-beta-clofibryl glucuronide. Consistent with a role for glucuronidation in the DNA damage observed, the glucuronidation inhibitor borneol diminished glucuronide formation from 100 microM clofibrate by 98% and returned comet areas to baseline levels. Collectively, these results suggest that the acyl glucuronide formed from clofibric acid is capable of migrating from its site of formation within the endoplasmic reticulum to generate strand nicks in nuclear DNA.
authors.affiliation: Molecular Toxicology Research Group, Department of Clinical and Experimental Pharmacology, University of Adelaide, Adelaide, SA 5005, Australia.
authors.forename: Roula
authors.initials: R
authors.lastname: Ghaoui
authors.forename: Benedetta C
authors.initials: BC
authors.lastname: Sallustio
authors.forename: Philip C
authors.initials: PC
authors.lastname: Burcham
authors.forename: Frank R
authors.initials: FR
authors.lastname: Fontaine
mesh_terms: D000818:Animals; D001892:Camphanes / Q000494:pharmacology; D016923:Cell Death; D002995:Clofibric Acid / Q000009:adverse effects* / Q000031:analogs & derivatives / Q000032:analysis* / Q000378:metabolism*; D020552:Comet Assay; D004249:DNA Damage; D004305:Dose-Response Relationship, Drug; D020719:Glucuronides / Q000032:analysis* / Q000378:metabolism*; D014453:Glucuronosyltransferase / Q000378:metabolism*; D022781:Hepatocytes / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D051379:Mice; D013997:Time Factors
chemical_list: C474801:1-O-clofibryl glucuronide; D001892:Camphanes; D020719:Glucuronides; D002995:Clofibric Acid; D014453:Glucuronosyltransferase; C022871:isoborneol